GlassScriptPhysician profile
Joseph M Ortenberg
NPI 1881682607
$4,570.11
in general payments reported to CMS, 2019-2025
22 companies · $729 in 2025
The $729 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,193 · 2020: $463 · 2021: $265 · 2022: $243 · 2023: $893 · 2024: $784 · 2025: $729.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,406.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $699.77 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $696.25 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $460.50 | 2019-2022 | |
| Pfizer INC. | $412.42 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $372.42 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $358.09 | 2019-2022 | |
| Amgen INC. | $303.72 | 2019-2025 | Repatha, Repatha |
| Abbott Laboratories | $241.78 | 2021-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Mitraclip |
| Philips North America LLC | $190.48 | 2020-2025 | (Ck4) Mcot, Extended Holter, Event |
| Sanofi-Aventis U.S. LLC | $159.29 | 2019-2024 | |
| Abiomed | $125.71 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $122.48 | 2019-2025 | Lifevest |
| Regeneron Healthcare Solutions, INC. | $89.53 | 2019 | |
| Astellas Pharma US INC | $65.97 | 2019 | |
| Merck Sharp & Dohme LLC | $56.07 | 2023-2024 | Verquvo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $55.03 | 2024 | Corevalve Evolut R |
| Kiniksa Pharmaceuticals International, Plc | $49.93 | 2024 | Arcalyst |
| Inspire Medical Systems, INC. | $33.76 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $24.53 | 2025 | Amvuttra |
| Baxter Healthcare | $19.06 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Braemar Manufacturing, LLC | $17.09 | 2019 | |
| Heartflow, INC. | $16.23 | 2023 | Ffrct |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Ortenberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.